We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$77.8B
AUM Growth
+$562M
Cap. Flow
-$1.46B
Cap. Flow %
-1.88%
Top 10 Hldgs %
10.8%
Holding
4,575
New
517
Increased
1,382
Reduced
1,468
Closed
614

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$693M
2
BABA icon
Alibaba
BABA
+$408M
3
BKNG icon
Booking.com
BKNG
+$406M
4
YHOO
Yahoo Inc
YHOO
+$284M
5
MU icon
Micron Technology
MU
+$265M

Sector Composition

Rank Sector Weight
1 Technology 8.31%
2 Consumer Discretionary 8.11%
3 Energy 8.03%
4 Healthcare 6.93%
5 Communication Services 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORMP icon
3851
Oramed Pharmaceuticals
ORMP
$165M
$126K ﹤0.01%
27,708
+10,705
+63% +$70.4K
PFX icon
3852
PhenixFIN
PFX
$83.9M
$126K ﹤0.01%
682
-10,255
-94% -$2.23M
SFXE
3853
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
$125K ﹤0.01%
27,544
-42,962
-61% -$196K
EGO icon
3854
PUT
Eldorado Gold
EGO
$8.31B
$122K ﹤0.01%
4,000
TEAR
3855
DELISTED
TearLab Corporation
TEAR
$121K ﹤0.01%
+4,571
New +$126K
LCTX icon
3856
Lineage Cell Therapeutics
LCTX
$257M
$119K ﹤0.01%
39,517
+3,064
+8% +$8.29K
LFVN icon
3857
LifeVantage
LFVN
$82.4M
$119K ﹤0.01%
13,066
+11,159
+585% +$102K
AUDC icon
3858
AudioCodes
AUDC
$244M
$118K ﹤0.01%
+25,968
New +$120K
TXMD icon
3859
TherapeuticsMD
TXMD
$23.8M
$118K ﹤0.01%
+530
New +$109K
WEN icon
3860
PUT
Wendy's
WEN
$1.33B
$117K ﹤0.01%
13,000
AUO
3861
DELISTED
AU Optronics Corp
AUO
$115K ﹤0.01%
22,661
-131,468
-85% -$600K
IMNN icon
3862
Imunon
IMNN
$6.35M
$114K ﹤0.01%
18
-34
-65% -$236K
NOG icon
3863
PUT
Northern Oil and Gas
NOG
$2.3B
$113K ﹤0.01%
2,000
-3,140
-61% -$301K
ORN icon
3864
Orion Group Holdings
ORN
$514M
$113K ﹤0.01%
+10,247
New +$107K
RYZ
3865
Ryerson Holding Corp
RYZ
$1.6B
$113K ﹤0.01%
11,368
-32,660
-74% -$368K
ARR
3866
Armour Residential REIT
ARR
$2.02B
$111K ﹤0.01%
751
-363
-33% -$56.6K
NCIT
3867
DELISTED
NCI, Inc.
NCIT
$110K ﹤0.01%
10,744
-800
-7% -$8.42K
CRC
3868
CALL
DELISTED
California Resources Corporation
CRC
$110K ﹤0.01%
+2,000
New +$120K
RSYS
3869
DELISTED
Radisys Corp
RSYS
$108K ﹤0.01%
46,194
-6,800
-13% -$16.1K
TRAW icon
3870
Traws Pharma
TRAW
$7.43M
$107K ﹤0.01%
+1
New +$245K
ADNC
3871
DELISTED
AUDIENCE INC COM STK (DE)
ADNC
$107K ﹤0.01%
24,390
-17,395
-42% -$83.8K
LSTA icon
3872
Lisata Therapeutics
LSTA
$15.2M
$106K ﹤0.01%
187
+49
+36% +$33.4K
CETV
3873
DELISTED
Central European Media Enterprises Ltd
CETV
$101K ﹤0.01%
31,500
-11,169
-26% -$28.7K
EXXI
3874
CALL
DELISTED
ENERGY XXI LTD COM SHS
EXXI
$99K ﹤0.01%
30,500
DRYS
3875
DELISTED
DryShips Inc. Common Stock
DRYS
0

Similar funds

D.E. Shaw & Co's Q4 2014 Portfolio in Review

As of Q4 2014, D.E. Shaw & Co held 4,575 positions worth $77.8B, up 0.73% from $77.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

D.E. Shaw & Co's Q4 2014 filing shows 517 new, 1,382 increased, 1,468 reduced and 614 closed positions. Its largest new stake was James River Group Holdings: 14,047,238 shares worth $320M. The largest sale was Apple, an estimated $693M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.9% a quarter earlier, followed by Consumer Discretionary and Energy.

  • D.E. Shaw & Co's largest Q4 2014 buy was James River Group Holdings: 14,047,238 shares worth $320M.
  • D.E. Shaw & Co added most to IBM in Q4 2014, an estimated $339M increase.
  • D.E. Shaw & Co's biggest Q4 2014 reduction was Apple, cutting an estimated $693M.
  • D.E. Shaw & Co fully exited TIM HORTONS INC COM, CANADA in Q4 2014, selling an estimated $110M.
  • D.E. Shaw & Co's ten largest holdings make up 11% of its $77.8B portfolio in Q4 2014.
  • D.E. Shaw & Co opened 517 new positions and closed 614 in Q4 2014.
  • D.E. Shaw & Co's portfolio value rose 0.73% quarter-over-quarter to $77.8B.

Based on D.E. Shaw & Co's 13F filing for Q4 2014, filed 17 Feb 2015.